Clinical Pharmacologist
US Food and Drug Administration
Silver Spring, Maryland
Mohsen Rajabi is a Pharmacologist in the Division of New Drug Bioequivalence Evaluation (DNDBE), Office of Study Integrity and Surveillance, Office Translational Science, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD. He received his Ph.D. from University of Maryland in Baltimore, MD. After completing a reaserch fellowship, he joined the Office of Study Integrity and Surveillance in 2015. He conducts study-directed and comprehensive surveillance inspections of firms that conduct pharmacokinetic, bioavailability/bioequivalence (BA/BE) in support of human drug applications. He also participate in working groups to develop and refine strategies to improve inspections planning, execution, evaluation, and to provide recommendations to CDER review divisions, while focusing on human subject safety and data integrity. In his free time, he enjoys outdoor activity and traveling.
Disclosure information not submitted.